Status:
NOT_YET_RECRUITING
High Risk of Death or Disability in Brain Hemorrhage: Role of Spot Sign and Secondary Markers
Lead Sponsor:
Centre Hospitalier de Gonesse
Conditions:
Intracerebral Hemorrhage
Cerebral Hemorrhage
Eligibility:
All Genders
18+ years
Brief Summary
This study looks at patients with brain hemorrhage to see if a special sign on brain scans, called the "Spot Sign," combined with other scan features, can predict a higher risk of death or disability....
Eligibility Criteria
Inclusion
- Spontaneous intracerebral hemorrhage confirmed by contrast-enhanced CT scan.
- Follow-up CT scan performed within 24 to 48 hours.
- Non-inclusion Criteria :
- Absence of initial contrast-enhanced CT or follow-up CT.
- Hematoma due to trauma, epidural hematoma (EDH), subdural hematoma (SDH), or subarachnoid hemorrhage (SAH).
Exclusion
- Patient deceased before the initial contrast-enhanced CT.
- Major missing clinical data.
Key Trial Info
Start Date :
October 15 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 15 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT07172542
Start Date
October 15 2025
End Date
May 15 2026
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de Gonesse
Gonesse, France, France